Nine Masts Capital’s Bausch Health BHC Stock Holding History

Nine Masts Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,000	Closed	-$15K	–	198
2018 Q3	$15K	Buy	+1,000	New	+$22.9K	﹤0.01%	278
2017 Q4	–	Sell	-1,000	Closed	-$78K	–	258
2017 Q3	$78K	Buy	+1,000	New	+$15.1K	0.01%	112

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $3.66B AUM 25.21% 1-Year Est. Return

Nine Masts Capital's BHC Position: Q3 2024 in Review

Nine Masts Capital sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 183,040 shares — an estimated $1.28M sold.

Nine Masts Capital first reported a position in BHC in Q3 2017 and held it in 9 quarters. The position peaked at $9.28M in Q1 2024. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

Nine Masts Capital reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
Nine Masts Capital sold 183,040 Bausch Health shares in Q3 2024, an estimated $1.28M.
Nine Masts Capital first reported a position in Bausch Health in Q3 2017 and held it in 9 quarters.
Nine Masts Capital's Bausch Health position peaked at $9.28M in Q1 2024.
211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Nine Masts Capital's 13F filing for Q3 2024, filed 12 Nov 2024.